These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11186915)

  • 1. [Effective melatonin therapy in a case of Machado-Joseph disease with insomnia].
    Takei A; Okawa M; Sasaki H; Hamada T; Tashiro K
    Rinsho Shinkeigaku; 2000 Jul; 40(7):736-40. PubMed ID: 11186915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep symptoms and their clinical correlates in Machado-Joseph disease.
    D'Abreu A; França M; Conz L; Friedman JH; Nucci AM; Cendes F; Lopes-Cendes I
    Acta Neurol Scand; 2009 Apr; 119(4):277-80. PubMed ID: 18771522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive fragmentary myoclonus in Machado-Joseph disease.
    dos Santos DF; Pedroso JL; Braga-Neto P; Silva GM; de Carvalho LB; Prado LB; Barsottini OG; do Prado GF
    Sleep Med; 2014 Mar; 15(3):355-8. PubMed ID: 24518960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficiency of melatonin in the treatment of insomnia].
    Morera AL; Henry M; Villaverde-Ruiz ML; Gracia-Marco R
    Actas Esp Psiquiatr; 2000; 28(5):325-9. PubMed ID: 11269911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease.
    Iranzo A; Muñoz E; Santamaria J; Vilaseca I; Milà M; Tolosa E
    Mov Disord; 2003 Oct; 18(10):1179-83. PubMed ID: 14534924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of melatonin in the immediate postoperative period in elderly patients].
    Leardi S; Tavone E; Cianca G; Barnabei R; Necozione S; Citone G; Simi M
    Minerva Chir; 2000 Nov; 55(11):745-50. PubMed ID: 11265147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
    van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W
    J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
    Takei A; Honma S; Kawashima A; Yabe I; Fukazawa T; Hamada K; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):181-5. PubMed ID: 11952922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep disorders in Machado-Joseph disease.
    Pedroso JL; Braga-Neto P; Martinez AR; Martins CR; Rezende Filho FM; Sobreira-Neto MA; Prado LB; do Prado GF; França MC; Barsottini OG
    Curr Opin Psychiatry; 2016 Nov; 29(6):402-8. PubMed ID: 27584711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-movement disorder heralds symptoms of Machado-Joseph disease years before ataxia.
    D'Abreu A; Friedman J; Coskun J
    Mov Disord; 2005 Jun; 20(6):739-41. PubMed ID: 15747372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders.
    Waldhauser F; Kovács J; Reiter E
    Exp Gerontol; 1998; 33(7-8):759-72. PubMed ID: 9951620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin as a hypnotic: pro.
    Zhdanova IV
    Sleep Med Rev; 2005 Feb; 9(1):51-65. PubMed ID: 15649738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep onset insomnia during childhood or poor fit between biology and culture: comment on van der Heijden et al. 'Prediction of melatonin efficacy by pre-treatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia'.
    Jenni OG
    J Sleep Res; 2005 Jun; 14(2):195-7; discussion 197-9. PubMed ID: 15910517
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin for insomnia in children with autism spectrum disorders.
    Andersen IM; Kaczmarska J; McGrew SG; Malow BA
    J Child Neurol; 2008 May; 23(5):482-5. PubMed ID: 18182647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairments in Machado-Joseph disease.
    Kawai Y; Takeda A; Abe Y; Washimi Y; Tanaka F; Sobue G
    Arch Neurol; 2004 Nov; 61(11):1757-60. PubMed ID: 15534186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
    Braam W; Didden R; Smits MG; Curfs LM
    J Child Neurol; 2008 Jun; 23(6):649-54. PubMed ID: 18539989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ramelteon: a novel treatment for the treatment of insomnia.
    Wurtman R
    Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin add-on in manic patients with treatment resistant insomnia.
    Bersani G; Garavini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):185-91. PubMed ID: 10800742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.